188P IPH5201 as monotherapy or in combination with durvalumab (D) in advanced solid tumours. (December 2022) - Imbimbo, M.; Hollebecque, A.; Italiano, A.; McKean, M.; Macarulla, T.; Castanon Alvarez, E.; Carneiro, B.A.; Mager, R.; Barnhart, V.; Murtomaki, E.; He, Y.; Cooper, Z.A.; et al.